Navigation Links
Ventana Medical Systems, Inc. Introduces Groundbreaking Laboratory Workflow Integration
Date:10/27/2011

TUCSON, Ariz., Oct. 27, 2011 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced today a first-of-its-kind integration of the VIRTUOSO digital pathology software and VANTAGE workflow management solution, bringing unprecedented workflow integration to the anatomic pathology lab.

The VIRTUOSO -VANTAGE integration enables pathologists and lab managers to track the progress of a slide from preparation to digitization along with other critical slide information, giving the lab unprecedented visibility into their processes to optimize lab workflow.

"In our continuing effort to further improve our comprehensive solution for the AP Lab, we asked pathologists and lab managers several key questions," explained Steve Burnell, PhD, lifecycle leader for advanced workflow. "How do you obtain feedback on slide quality from the pathologist? How do you ensure that cases reviewed are of the highest quality? How do you receive updates on the status of cases or urgent orders? The integration of VIRTUOSO with VANTAGE effectively answers these questions by providing complete visibility into key laboratory processes such as workflow events, case history, slide quality and slide processing."

With this integrated solution, Pathologists using VIRTUOSO will be able to:

  • Check the histology status of a pending slide
  • Review the entire histology processing history of a slide
  • Provide image quality feedback to the histotechnologist for corrective action tracking

Lab managers using VANTAGE will be able to:

  • Review the pathologist workflow of a case
  • Run quality reports on digital slides

The VANTAGE workflow solution is another Ventana first in the industry. It automates, streamlines, and integrates lab work and information flow to provide maximum productivity and patient safety gains. VIRTUOSO image management software is a web-based application that orchestrates the workflow around the digital slide, from the moment the slide is scanned until the slide image is viewed and the results reported.

With this integration, slide data is now seamlessly shared between VIRTUOSO and VANTAGE. This facilitates the exchange of information between pathologists and lab managers, resulting in improved communications and a more streamlined workflow while maintaining high quality. Workflow optimization is becoming increasingly important in modern pathology labs, particularly as lab professionals adopt digital pathology into their existing glass slide workflow.

Ventana provides complete digital pathology solutions. The iScan Coreo Au slide scanner is integrated with VIRTUOSO for image management functionality from acquisition through reporting.  The VENTANA iScan HT slide scanner, launching soon, will also be integrated with VIRTUOSO.  To view the entire suite of digital pathology products, including the VIRTUOSO -VANTAGE integration, visit Ventana at booth #200 during Pathology Visions 2011 at the Manchester Grand Hyatt, San Diego, from Oct. 30 – Nov. 4, 2011.  The VENTANA iScan HT is for research use only. Not for use in diagnostic procedures.  Ventana products are for in vitro diagnostic use for specific applications, and are research use only for other applications.

About Ventana Medical Systems, Inc.

Ventana Medical Systems, Inc. ("VMSI") (SIX: RO, ROG; OTCQX: RHHBY), a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used in clinical histology and drug development research laboratories worldwide. The company's "Smart Systems" – intuitive, integrated staining and workflow management platforms that optimize laboratory efficiencies to reduce errors – support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, VMSI is driving personalized medicine through accelerated drug discovery and the development of "companion diagnostics" to identify the patients most likely to respond favorably to specific therapies. Visit www.ventana.com to learn more.

VENTANA, the VENTANA logo, VANTAGE, iScan,  and VIRTUOSO are trademarks of Roche.

VMSI Media Relations:

Jacqueline Bucher
Director, Corporate Communications
Phone: 520-877-7288
e-mail: jacquie.bucher@ventana.roche.com


'/>"/>
SOURCE Ventana Medical Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Endologix Announces First Clinical Implant of Ventana™ Stent Graft
2. CareGiver, Ventana Medical Systems, Inc. Remote Instrument Support, Has Expanded to Include the Ventana BenchMark ULTRA Automated Stainer
3. Ventana Medical Systems, Inc. Launches Virtuoso Software for Digital Pathology
4. Ventana Medical Systems, Inc. Receives FDA Approval for the First Fully Automated Diagnostic Assay for HER2 Gene Status Determination in Breast Cancer Patients
5. Ventana Medical Systems, Inc. Unveils High-throughput Slide Scanner for Digital Pathology
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. Globus Medical Raises $110 Million in Series E Financing Round
10. Quark Pharmaceuticals Appoints New Chief Medical Officer
11. Boston University Biomedical Engineers Find Chink in Bacterias Armor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... Calif. , Dec. 6, 2016 /PRNewswire/ ... held, clinical-stage medical dermatology and aesthetics company, ... a privately held specialty pharmaceutical company focused ... inflammatory skin conditions, including psoriasis, atopic dermatitis ... the agreement, Sienna will make an undisclosed ...
(Date:12/6/2016)... Mass. , Dec. 6, 2016  Blueprint Medicines ... discovering and developing targeted kinase medicines for patients with ... an underwritten public offering of $125,000,000 million in shares ... to grant the underwriters a 30-day option to purchase ... of its common stock in connection with the public ...
(Date:12/6/2016)... Dec. 6, 2016  In response to the tragic ... every 25 minutes, a respected group of local and ... provide a holistic suite of services to help Medicaid-eligible ... on his own experience trying to help family and ... Justin Lanning launched 180 Health Partners ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... ... announce that its fully redesigned website, which launched October 17, 2016, features comprehensive ... responsive design and easy-to-navigate layout. Visitors and patients can discover the latest clinical ...
(Date:12/7/2016)... ... 07, 2016 , ... 1105 Media’s Live From program has ... Awards competition. Live From won in the Use of Social Media category. The ... projects undertaken by the media industry’s most innovative marketing professionals. , ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... portable bioelectronic medicine device WellnessPro Plus for consumers and healthcare professionals to ... WellnessPro platform by expanding the treatment modalities available in a single device. ...
(Date:12/7/2016)... ... ... “Walking With God: Inspirational Lessons from My Life's Journey”: a sometimes serious, sometimes ... direction in their lives. “Walking With God: Inspirational Lessons from My Life's Journey” is ... , Sanford says, “I enjoy sharing the true stories in my book as ...
(Date:12/7/2016)... ... December 07, 2016 , ... Dr. Greg Leyer, the ... Probiotic Association’s Washington DC workshop on November 2nd. The conference was an opportunity ... probiotic dietary supplement regulations. , Dr. Leyer spoke about two main topics ...
Breaking Medicine News(10 mins):